Rho Federal Systems Division, Inc. NIAID DAIT SACCC
Project Number4UM2AI117870-08
Former Number3UM2AI117870-07W2
Contact PI/Project LeaderDAVID, GLORIA
Awardee OrganizationRHO FEDERAL SYSTEMS DIVISION, INC.
Description
Abstract Text
This project is a one-year extension of the consolidated DAIT Statistical and Clinical Coordinating Center
(DAIT SACCC). The extension will enable crucial continuity of services while the individual successor
contracts assuming the work of the DAIT SACCC are awarded and any necessary transitions occur. The
DAIT SACCC supports research in the areas of asthma and allergic diseases, autoimmune diseases, and
transplantation. The objective of the DAIT SACCC is to provide efficient coordination of the following
services: protocol development, study initiation and management, statistical design and analysis, clinical
site monitoring, ancillary services, data management, and safety oversight. During the extension, the DAIT
SACCC will continue to (1) provide staff experienced in research conducted by DAIT-supported consortia
and organize these staff in an administrative structure that manages resources efficiently, is responsive to
the needs of the research consortia and DAIT, and facilitates communication and collaboration; (2) provide
experienced scientists and statisticians who, in collaboration with clinical investigators and DAIT officials,
design and analyze studies across the full scope of research; (3) facilitate the development, review, and
revision of protocols and protocol-related documents through dedicated protocol teams; (4) provide study
initiation and study management functions required for the efficient, valid, and ethical conduct of studies;
(5) provide well-developed procedures and personnel for the monitoring of clinical sites; (6) provide efficient
and accurate tracking and reconciliation of specimen collection and distribution; (7) provide integrated and
secure information management systems and procedures for the collection of clinical and mechanistic data;
(8) help ensure patient safety by providing high-quality serious adverse event (SAE) reporting and Data
and Safety Monitoring Board (DSMB) reports; and (9) provide tools, infrastructure, and analytical support in
the planning, implementation, analysis, and dissemination of high dimensional mechanistic studies.
Public Health Relevance Statement
This project is a one-year extension of a coordinating center that provides investigators with expertise,
tools, and support to conduct effective clinical research studies in the areas of allergy, immunology, and
transplantation. Services include the design of the studies, the capture of necessary data, the management
of all the clinical sites, the oversight of potential safety issues, and the analysis of the data providing
results. By continuing to support investigators as they conduct successful research studies, the public gains
a better understanding of the mechanisms of these disease areas that yields improved health for patients.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Allergic DiseaseApplied ResearchAreaAsthmaAutoimmuneAutoimmune DiseasesAwardBasic ScienceBiological Specimen BanksClinicalClinical InvestigatorClinical ResearchClinical Trials Data Monitoring CommitteesCollaborationsCollectionCommunicable DiseasesCommunicationContractsDataData AnalysesData CollectionData ReportingDevelopmentDiseaseEnsureEthicsEventHealthHuman ResourcesHypersensitivityImmune System DiseasesImmunologyIndividualInfrastructureLaboratoriesManagement Information SystemsMissionMonitorNational Institute of Allergy and Infectious DiseaseOrgan Transplant ResearchPatientsPreparationProceduresProcessProtocols documentationPublicationsRandomizedReportingResearchResearch PersonnelResearch SupportResourcesSafetyScientistSecureSerious Adverse EventServicesSolidStandardizationStatistical Data InterpretationStructureStudy SubjectSystemTechnologyTestingTrainingTransplantationWorkWritingclinical research sitedata managementdesignexperiencehigh dimensionalityimprovedinstrumentmeetingsmemberpatient safetyperformance sitepreventprogramsprotocol developmentresearch studyrhosample collectionstatisticstool
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
362726007
UEI
XCPKWEM58CV5
Project Start Date
07-May-2015
Project End Date
30-April-2023
Budget Start Date
17-May-2022
Budget End Date
30-April-2023
Project Funding Information for 2022
Total Funding
$16,762,800
Direct Costs
$10,051,449
Indirect Costs
$6,711,351
Year
Funding IC
FY Total Cost by IC
2022
National Institute of Allergy and Infectious Diseases
$16,588,800
2022
National Institute of Diabetes and Digestive and Kidney Diseases
$174,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 4UM2AI117870-08
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 4UM2AI117870-08
Patents
No Patents information available for 4UM2AI117870-08
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 4UM2AI117870-08
Clinical Studies
No Clinical Studies information available for 4UM2AI117870-08
News and More
Related News Releases
No news release information available for 4UM2AI117870-08
History
No Historical information available for 4UM2AI117870-08
Similar Projects
No Similar Projects information available for 4UM2AI117870-08